# FDA Inspection 1304150 - NEOLPHARMA, INC. - March 10, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/0f95eddc-787e-4d59-aecb-be0b8a4ebb5a
Source feed: FDA_Inspections

> FDA Inspection 1304150 for NEOLPHARMA, INC. on March 10, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304150
- Company Name: NEOLPHARMA, INC.
- Inspection Date: 2026-03-10
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: San Juan District Office

## Related Documents

- [FDA Inspection 1166181 - 2022-04-01](https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/333f1bda-c222-419f-af7c-dea739c8f225)
- [FDA Inspection 1078192 - 2019-02-05](https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/a81b069e-73c1-4020-b82d-ac7363881d3b)
- [FDA Inspection 1018694 - 2017-06-07](https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/28c019ed-583a-478d-80cf-0d3e38d635c3)
- [FDA Inspection 929761 - 2015-06-18](https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/08005574-5b0f-4664-ac10-072c0a3c1feb)
- [FDA Inspection 822275 - 2013-03-07](https://www.globalkeysolutions.net/records/fda_inspections/neolpharma-inc/72ffc875-2c5b-4c8c-beab-afa0a5720f31)

Company: https://www.globalkeysolutions.net/companies/neolpharma-inc/4a216d1c-7206-434a-82df-ca1a8f1fe43b

Office: https://www.globalkeysolutions.net/offices/san-juan-district-office/27661cbf-5ba6-4c1b-9b39-4d6df63ca0e8